← Leaderboards
Ajay V. Maker
University Of California, San Francisco
$3,064,358
Attributed
$3,064,358
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370.4K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,064,358 · 2
By mechanism
R37$2,155,268 · 1
K08$909,090 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Lawrence Fong$19,816,074
- Hilde Schjerven$2,179,645
- Christopher Craig Dvorak$1,385,756
- Mickie H Cheng$623,588
- Rahul Aggarwal$5,953,056
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyResectedResponseLiverOverexpressionOperative Surgical ProceduresEnvironmentLymphocyteImmunotherapyInfiltrationMalignant NeoplasmsMetastatic Neoplasm To The LiverNeoplasm MetastasisNeoplastic CellColorectalCancer EtiologyImmuneImmune ResponseColonic NeoplasmsImmune SystemBiologyColon CarcinomaCancer CellT-Lymphocyte
Grant awards (11)
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$361,836
R37 · FY2025 · CA · contact PI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$359,032
R37 · FY2024 · CA · contact PI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$370,370
R37 · FY2023 · CA · contact PI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$332,488
R37 · FY2022 · CA · contact PI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$365,771
R37 · FY2021 · CA · contact PI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases$365,771
R37 · FY2020 · CA · contact PI
Enhancing anti-tumor immune responses in colon cancer metastases$181,818
K08 · FY2018 · CA · contact PI
Enhancing anti-tumor immune responses in colon cancer metastases$181,818
K08 · FY2017 · CA · contact PI
Enhancing anti-tumor immune responses in colon cancer metastases$181,818
K08 · FY2016 · CA · contact PI
Enhancing anti-tumor immune responses in colon cancer metastases$181,818
K08 · FY2015 · CA · contact PI
Enhancing anti-tumor immune responses in colon cancer metastases$181,818
K08 · FY2014 · CA · contact PI